Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of Neurology (AAN) Annual Meeting

NEW YORK, April 21, 2023 -- Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today... | April 21, 2023

Related Keywords

China ,United States ,United Kingdom ,New York ,Boston ,Massachusetts ,Japan ,Germany ,American ,British ,Mark Jacobson ,Stuartj Tepper ,Axsome Mo ,Darren Opland ,Eileen Leary ,Zachariah Thomas ,Samantha Floam ,Hans Van Dongen ,Sk Biopharmaceuticals Co Ltd ,Affairs At Axsome ,Clinical Development At Axsome ,Axsome Therapeutics Inc ,Geisel School Of Medicine At Dartmouth ,Corporate Communications ,American Academy Of Neurology ,Nasdaq ,Airway Pressure ,Study Topline Data Press ,Drug Administration ,Professor At Washington State University ,Us Drug Enforcement Agency On ,Continuous Positive Airway Pressure ,Annual Meeting ,Participants During ,British Columbia Cognitive Complaints Inventory ,Epworth Sleepiness Scale ,Washington State University ,Cognitive Function ,Cognitive Impairment Associated ,Excessive Daytime Sleepiness ,Obstructive Sleep Apnea ,Senior Director ,Clinical Development ,Preclinical Pharmacology ,Potential Mechanisms ,Executive Director ,Medical Affairs ,Solriamfetol Real World Experience Study ,Experience During Follow Up ,Identifying Areas ,Unmet Need Among People ,Inadequate Response ,Prior Acute Therapies ,Risk Factors ,Acute Migraine ,Geisel School ,Cognitive Health ,Apnea Participants During ,Randomized Placebo Controlled Study ,Digit Symbol Substitution Test ,Repeatable Battery ,Neuropsychological Status ,Digit Symbol Substitution ,Patient Global Impression ,Real World Experience ,Enforcement Agency ,Full Prescribing Information ,Medication Guide ,Prescribing Information ,Molecular Solubility Enhanced Inclusion Complex ,Axsome Therapeutics ,Topline Data Press Release ,Nc Stock Exchange ,News ,Information ,Press Release ,Few ,Pril ,023 ,Axsome ,Iopharmaceutical ,Company ,Developing ,End ,Elivering ,Novel ,Therapies ,Or ,The ,Management ,F ,Central ,Nervous ,Ystem Axsm Us05464t1043 ,